20/11/2017 20:00:00

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tesla, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 11, 2017 – TSLA

Related content
09 Oct - 
SHAREHOLDER ALERT: TSLA PDD AMPE NVRO ORCL NLSN ZN SBGI..
08 Oct - 
The Klein Law Firm Reminds Investors of Class Actions o..
08 Oct - 
ATTENTION TESLA INVESTORS:  Kaskela Law LLC Announces O..
Related debate
15 Oct - 
For en gang skyld en positiv EU nyhed :) Man kan så kun..
15 Oct - 
EU frygter, at den europæiske bilindustri og dens 13 mi..
12 Oct - 
Hehe, det lyder som om vi er meget enige :)

NEW YORK, Nov. 20, 2017 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Tesla, Inc. ("Tesla") (NASDAQ:TSLA) between May 4, 2016 and October 6, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. To get more information go to:

https://www.zlk.com/plsra-c/tesla-inc?wire=3

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) contrary to defendants’ representations, Tesla had severely inadequate inventory and was woefully unprepared to launch its Model 3 sedan as anticipated; and (2) as a result, Tesla’s public statements were materially false and misleading at all relevant times.

If you suffered a loss in Tesla you have until December 11, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

30 Broad Street - 24th Floor

New York, NY 10004

Tel: (212) 363-7500

Toll Free: (877) 363-5972

Fax: (212) 363-7171

www.zlk.com 

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
15 Oct
TSLA
EU frygter, at den europæiske bilindustri og dens 13 mio. ansatte vil blive tabt i kapløbet om masse..
5
11 Oct
TSLA
Jeg har en god shortposition i Tesla men overvejer at træde ud nu. Den er ekstremt volatil (nærmest ..
1

Regulatory news

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
IMRALDI™, Biogen’s Adalimumab Biosimilar Referencing Humira®, Is Launched in the European Union
2
Glance Reports Third Quarter 2018 Results
3
Axiom Real-Time Metrics Exhibiting at OCT Pacific Northwest in Vancouver
4
Ctrip and KLM Sign Strategic Partnership Agreement
5
Atos and Siemens team up to enable enterprises to deploy IoT applications on private Cloud

Related stock quotes

Tesla Inc 271.78 0.0% Stock price unchanged

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 October 2018 00:17:18
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181005.3 - EUROWEB4 - 2018-10-18 01:17:18 - 2018-10-18 00:17:18 - 1000 - Website: OKAY